Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2Thoracic 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 378Pituitary Neoplasms 159Multiple Endocrine Neoplasia Type 1 150Thyroid Cancer, Papillary 122Pheochromocytoma 107Carcinoma, Neuroendocrine 93Thyroid Neoplasms 74Paraganglioma 68Carcinoid Tumor 66Neoplasms 54Thyroid Carcinoma, Anaplastic 50Adrenocortical Carcinoma 47Adrenal Gland Neoplasms 46Neoplasm Metastasis 40Insulinoma 39Pancreatic Neoplasms 36Gastro-enteropancreatic neuroendocrine tumor 36Adenoma, Islet Cell 36Carcinoma, Medullary 29Neuroblastoma 28Adenocarcinoma, Follicular 28Hyperaldosteronism 25Prostatic Neoplasms 24Lung Neoplasms 24Obesity 23Brain Neoplasms 22Pituitary Diseases 21Differentiated Thyroid Cancer 20Cushing Syndrome 20Sarcoma 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hyponatremia × Endocrine × Clear all
NCT03636568 2024-07-23

DHAPS

Washington University School of Medicine

Phase NA Completed
300 enrolled
Endocrine

Hyponatremia, Pituitary Diseases, Pituitary Neoplasms

NCT02727686 2019-11-25

Post-Operative Water Load Following Transsphenoidal Pituitary Surgery

St. Joseph's Hospital and Medical Center, Phoenix

Phase NA Completed
30 enrolled
Endocrine

Hyponatremia, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡